Augustina Isioma Ikusemoro: An Underrecognized Cause of Severe Thrombocytopenia Following Transfusion
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Sudden severe thrombocytopenia after transfusion?
Think Post-Transfusion Purpura (PTP).
One of the most under-recognized yet critical delayed transfusion reactions in clinical practice is Post-Transfusion Purpura (PTP) — and missing it can delay life-saving treatment.
What is PTP?
A rare, immune-mediated complication that typically appears 5–10 days after transfusion, most often in previously pregnant or transfused patients, especially women.
What causes it?
The development of platelet alloantibodies, commonly anti-HPA-1a, which trigger destruction of both transfused platelets and the patient’s own platelets.
What happens clinically?
- Sudden severe thrombocytopenia (less than 10 × 10⁹/L)
- Petechiae, purpura, mucosal bleeding
- Risk of serious hemorrhage if untreated
Key diagnostic clues.
- Recent transfusion history
- Critically low platelet count
- Detection of anti-platelet antibodies
- Exclusion of other causes like TTP and ITP
Treatment is urgent — and effective when started early.
- IVIg (first-line therapy)
- Steroids as adjunct
- Plasma exchange in refractory cases
Avoid platelet transfusion unless life-threatening bleeding.
The most important takeaway?
PTP is treatable — but only if recognized early.
When unexplained severe thrombocytopenia appears days after transfusion, pause and consider PTP.
Early recognition saves lives.
Signature of Blood Doki.
Educate. Empower. Elevate.”
Other posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
Sep 5, 2026, 16:28Jon Douglas: Imperial College London Review Maps Key Pathways in Autoimmune Thrombosis
-
Sep 5, 2026, 16:21Kelly Anderson: Bilateral Foot Pain and Purple Toes – Spotting Vascular Complications in Polycythemia Vera
-
Sep 5, 2026, 16:16Hazem Abosheaishaa: Beta-Blocker Selection Matters – Multi-Institutional Cohort Insights on PVT and Survival in Cirrhosis
-
Sep 5, 2026, 16:08Indre Ceponiene: Major Gaps in Secondary Cardiovascular Prevention Across Europe
-
Sep 5, 2026, 16:03W. Alberto Sifuentes Giraldo: Why Obstetric Cases Are Missed Under 2023 ACR/EULAR APS Criteria
-
Sep 5, 2026, 15:58Srikanth Nalla: A Case of Saddle Pulmonary Embolism
-
Sep 5, 2026, 15:55COPD-specific Pulmonary Embolism Diagnostic Strategy – Thrombosis and Haemostasis
-
Sep 5, 2026, 15:41Sam Tsimikas on Lp(a) HORIZON Topline Results – What Missed Endpoints Mean for Cardiovascular Risk
-
Sep 5, 2026, 15:32Stefano Garzon: SELUTION DeNovo HBR – Weren’t HBR Patients Supposed to Bleed More with DES?